The Immunotherapeutics and Vaccine Summit - CHI's fifth annual meeting - novel vaccines: adjuvants and delivery systems: part 1.
The Fifth Annual Immunotherapeutics and Vaccine Summit (ImVacS), held in Boston, included topics covering new developments in the field of adjuvants and delivery systems for vaccines. This conference report highlights selected presentations on improving vaccine quality and persistence through adjuvants, the development of AS04-adjuvanted Cervarix, and research on new adjuvants. Adjuvants discussed include thymalfasin, nutritive immune-enhancing delivery system (NIDS), W805EC, MIMOPATH and ISCOMATRIX; the use of lasers as adjuvants is also highlighted.
Jones
Susan Dana
SD
BioProcess Technology Consultants, 12 Gill Street, Suite 5450, Woburn, MA 01801, USA. sjones@bioprocessconsultants.com
D000276:Adjuvants, Immunologic; D016503:Drug Delivery Systems / Q000639:trends*; D015195:Drug Design; D055808:Drug Discovery; D006801:Humans; D053685:Laser Therapy; D007834:Lasers; D014612:Vaccines / Q000008:administration & dosage* / Q000276:immunology
D000276:Adjuvants, Immunologic; D014612:Vaccines